Results 191 to 200 of about 493,409 (267)

Treatment of Obstructive Sleep Apnea. Prospects for Personalized Combined Modality Therapy. [PDF]

Ann Am Thorac Soc, 2016
Deacon NL, Jen R, Li Y, Malhotra A.
europepmc   +1 more source

Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening. [PDF]

BMC Cancer, 2016
Kalanxhi E, Hektoen HH, Meltzer S, Dueland S, Flatmark K, Ree AH.   +5 more
europepmc   +1 more source

Combined modality therapy in Stage IIIA non-small cell lung cancer: clarity or confusion despite the highest level of evidence? [PDF]

J Radiat Res, 2017
Jeremic B, Casas F, Dubinsky P, Gomez-Caamano A, Cihoric N, Videtic G, Latinovic M.   +6 more
europepmc   +1 more source

Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities [PDF]

, 2018
et al,, Michalski, Jeff M
core   +1 more source

90: Population-Based Analysis of Treatment Factors and Outcomes of Combined Modality Therapy with Low-Dose-Rate Brachytherapy (LDR-PB) Implant with External Beam Radiotherapy (EBRT) for High and Intermediate-Risk Prostate Cancer

, 2020
Justin Oh, Ingrid Spadinger, Vincent Lapointe, James Morris   +3 more
openalex   +1 more source

Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.

JAMA Oncol, 2018
Pezzi TA, Schwartz DL, Mohamed ASR, Welsh JW, Komaki RU, Hahn SM, Sepesi B, Pezzi CM, Fuller CD, Chun SG.   +9 more
europepmc   +1 more source

Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer. [PDF]

J Thorac Oncol, 2019
Schild SE, Fan W, Stinchcombe TE, Vokes EE, Ramalingam SS, Bradley JD, Kelly K, Pang HH, Wang X.   +8 more
europepmc   +1 more source

Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer. [PDF]

Clin Lung Cancer, 2017
Zaki M, Dominello M, Dyson G, Gadgeel S, Wozniak A, Miller S, Paximadis P.   +6 more
europepmc   +1 more source

Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer. [PDF]

Front Oncol, 2016
Dal Pra A, Locke JA, Borst G, Supiot S, Bristow RG.   +4 more
europepmc   +1 more source

Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma.

JAMA Oncol, 2019
Jhawar SR, Rivera-Núñez Z, Drachtman R, Cole PD, Hoppe BS, Parikh RR.   +5 more
europepmc   +1 more source